Advanced Search
Displaying assets from 1 to 30 out of 18
-
Description Platelet inhibition. Note: Platelet Inhibition as demonstrated by the mean and standard deviation of P2Y12 (PRU) values for each patient. The solid line represents the cohort mean P2Y12 of 164.75...
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosisVARGAS et al. - Journal of Thrombosis and HaemostasisJ Thromb Haemost vol. 19, January 2021
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description Anti‐coagulation/antiplatelet therapy
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description Disposition of patients who were eligible for study enrollment. IV, intravenous; ECMO, extracorporeal membrane oxygenation; prematurity, <37 wks’ gestational age at birth
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description TABLE
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description TABLE
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description TABLE
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description TABLE
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description TABLE
Article Title: Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Publication Title: Artificial Organs -
Description TABLE
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description ADP‐induced platelet aggregation and cangrelor dose response. Maximal platelet aggregation in response to 20 µmol/L ADP is depicted for each participant in (A) cohort 1 and (B) cohort 2 before (1...
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description TABLE
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description Assessment of platelet reactivity. Patients with stable CAD taking 81 mg of aspirin were given a 2 hour infusion of cangrelor plus 600 mg of clopidogrel at the end of the cangrelor infusion (at 2...
Article Title: Pharmacodynamic Effects When Clopidogrel is Given Before Cangrelor Discontinuation
Publication Title: Journal of Interventional Cardiology -
Description . Mean concentration versus time profiles for both treatment arms. For both doses, cangrelor was administered by intravenous push over 30 seconds followed immediately by a 1‐hour infusion....
Article Title: Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist
Publication Title: The Journal of Clinical Pharmacology -
Description Cangrelor dose response maximal efficacy model (Emax). A, Plasma concentrations of cangrelor and the metabolite AR‐C69712XX during and after drug infusion. The predicted pharmacodynamic...
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description TABLE
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis -
Description Mechanism of action of cangrelor. Cangrelor reversibly binds to the ADP (adenosine diphosphate) binding site. Other P2Y12 inhibitors are also included for comparison. Ticagrelor binds to an...
Article Title: Cangrelor
Publication Title: Practical Diabetes -
Description Microfluidic phenotyping of patient response to cangrelor administration. Thrombus formation in response to surface‐immobilized collagen was measured for each participant in (A) cohort 1 and (B)...
Article Title: Cangrelor PK/PD analysis in post‐operative neonatal cardiac patients at risk for thrombosis
Publication Title: Journal of Thrombosis and Haemostasis